NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/16/2026
Back to search
Official data from USPTO
DESIGN. ANALYZE. ADVANCE.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DESIGN. ANALYZE. ADVANCE.
ST13
US500000099318283Class
35, 42, 45
Filing
99318283
Registration
8300692
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
06/16/2026
Trademark type
Word
Nice classes
35, 42, 45
Filing date
08/04/2025
Registration date
06/16/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2026
Last transaction
06/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/24/2025
First use in commerce
07/24/2025
Drawing code
4
Owner type
16
Owner location
PHILADELPHIA, PA, US
Examiner
ALLEN, MACKENZIE M
Law office
M30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BIOMEDICAL STATISTICAL CONSULTING IP LLC
Representatives
Marc P. Misthal Offit Kurman, P.A.
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting public awareness of clinical trial resultsreporting and presentation of clinical trial results; Providing consulting services in the field of regulatory submission management to medicalbiopharmaceutical and biotechnology companies to assist them with the submission of clinical trial results for applications for new pharmaceuticals and medical devices with governmental regulatory bodies; Regulatory submission managementresponding to inquiries regarding clinical trials from governmental regulatory bodies; Customer servicesresponding to participant inquiries for others regarding clinical trials
Class 42
Consulting services for pharmaceuticalmedical devicebiotechnologymedical research industries; consulting services in the field of expert review of proposed clinical trial design; software as a service (SaaS) featuring software for statistical analysis and simulation tools for clinical trial designanalysisoptimization; providing an online non-downloadable computer software platform for running in vivo studies; providing an online non-downloadable computer software platform for running in silico studies; data modeling and statistical consulting services for the pharmaceuticalmedical devicebiotechnologymedical research industries; designdevelopment and implementation of software for in vivo simulations; designdevelopment and implementation of software for in silico simulations
Class 45
Representation of clients in biomedical and pharmaceutical regulatory proceedings
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/16/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/28/2026
PUBO
PUBLISHED FOR OPPOSITION
04/28/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/22/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/30/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
03/30/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/30/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
03/30/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/30/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/20/2026
GNRT
NON-FINAL ACTION E-MAILED
03/20/2026
CNRT
NON-FINAL ACTION WRITTEN
03/20/2026
DOCK
ASSIGNED TO EXAMINER
12/17/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/11/2025
MAFR
APPLICATION FILING RECEIPT MAILED
08/04/2025
NWAP
NEW APPLICATION ENTERED
08/04/2025
Continuous trademark protection
Get notified about every new filing that threatens DESIGN. ANALYZE. ADVANCE. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.